Cure Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
RYNE Biotechnology Inc.Mar 2024SEC filingmedium confidence
BiotechCambridge, US
Peter Fuhrken(Director)Howard Federoff(Executive Officer, Director)Nick Manusos(Executive Officer, Director)Martin Ostrowski(Executive Officer)Jonathan Yeh(Director)
BoardJeff Goater(Director)in
Board seatDavid Fallace· per SEC Form D · $81.8M raise · filed Mar 2024
Co-investorsThe Column Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.